​

Zai Lab (ZLAB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Zai Lab Revenue Highlights

Latest Revenue (Y)

$398.99M

Latest Revenue (Q)

$100.50M

Main Segment (Y)

Zejula

Zai Lab Revenue by Period

Zai Lab Revenue by Year

DateRevenueChange
2024-12-31$398.99M49.59%
2023-12-31$266.72M24.03%
2022-12-31$215.04M49.01%
2021-12-31$144.31M194.77%
2020-12-31$48.96M277.04%
2019-12-31$12.98M9930.55%
2018-12-31$129.45K100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

Zai Lab generated $398.99M in revenue during NA 2024, up 49.59% compared to the previous quarter, and up 3072.74% compared to the same period a year ago.

Zai Lab Revenue by Quarter

DateRevenueChange
2024-06-30$100.50M15.32%
2024-03-31$87.15M32.38%
2023-12-31$65.83M-4.91%
2023-09-30$69.23M0.53%
2023-06-30$68.86M9.66%
2023-03-31$62.80M0.31%
2022-12-31$62.60M8.80%
2022-09-30$57.54M19.44%
2022-06-30$48.18M3.11%
2022-03-31$46.72M5.78%
2021-12-31$44.17M2.48%
2021-09-30$43.10M16.70%
2021-06-30$36.94M83.73%
2021-03-31$20.10M33.19%
2020-12-31$15.09M3.02%
2020-09-30$14.65M33.25%
2020-06-30$10.99M33.79%
2020-03-31$8.22M76.92%
2019-12-31$4.65M-5.58%
2019-09-30$4.92M187.69%
2019-06-30$1.71M-
2019-03-31$1.71M1220.95%
2018-12-31$129.45K100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30--

Zai Lab generated $100.50M in revenue during Q2 2024, up 15.32% compared to the previous quarter, and up 160.05% compared to the same period a year ago.

Zai Lab Revenue Breakdown

Zai Lab Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Qinlock$28.83M$19.24M$14.96M$11.62M-
Zejula$187.08M$168.84M$145.19M$93.58M$32.14M
Nuzyra$43.20M$21.66M$5.20M$3.00K-
Optune$40.48M$46.97M$47.32M$38.90M$16.42M
Other----$402.00K

Zai Lab's latest annual revenue breakdown by segment (product or service), as of Dec 24: Zejula (62.45%), Nuzyra (14.42%), Optune (13.51%), and Qinlock (9.62%).

Quarterly Revenue by Product

Product/ServiceDec 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Jun 20
Zejula$141.58M$45.50M$41.61M$41.59M$42.96M$42.68M$42.33M$39.21M$34.05M$29.60M$29.45M$28.16M$23.37M$12.61M$13.79M
Nuzyra$33.29M$9.91M$6.07M$5.48M$4.64M$5.47M$1.60M$1.55M$1.31M$742.00K-----
Optune$28.00M$12.48M$8.37M$11.56M$13.69M$13.34M$12.27M$10.66M$11.59M$12.80M$11.59M$10.65M$9.54M$7.13M$5.42M
Qinlock$22.73M$6.09M$4.71M$5.70M$7.53M$1.31M$5.83M$5.54M$623.00K$2.96M$2.93M$4.29M$4.03K--
Other-------------$367.00K-

Zai Lab's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Zejula (62.76%), Nuzyra (14.75%), Optune (12.41%), and Qinlock (10.08%).

Zai Lab Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ALNYAlnylam Pharmaceuticals$2.25B$420.15M
PTCTPTC Therapeutics$806.78M$135.42M
APLSApellis Pharmaceuticals$709.95M$176.57M
BPMCBlueprint Medicines$508.82M$128.18M
ZLABZai Lab$398.99M$100.50M
KRYSKrystal Biotech$290.51M$83.84M
LEGNLegend Biotech$285.14M$93.99M
ASNDAscendis Pharma$266.72M$95.89M
MDGLMadrigal Pharmaceuticals$180.13M$62.17M
ROIVRoivant Sciences$124.80M$9.02M
CCCCC4 Therapeutics$20.76M-
CGEMCullinan Oncology--
AKROAkero Therapeutics--
ERASErasca--

ZLAB Revenue FAQ

What is Zai Lab’s yearly revenue?

Zai Lab's yearly revenue for 2024 was $398.99M, representing an increase of 49.59% compared to 2023. The company's yearly revenue for 2023 was $266.72M, representing an increase of 24.03% compared to 2022. ZLAB's yearly revenue for 2022 was $215.04M, representing an increase of 49.01% compared to 2021.

What is Zai Lab’s quarterly revenue?

Zai Lab's quarterly revenue for Q2 2024 was $100.5M, a 15.32% increase from the previous quarter (Q1 2024), and a 45.95% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $87.15M, a 32.38% increase from the previous quarter (Q4 2023), and a 38.78% increase year-over-year (Q1 2023). ZLAB's quarterly revenue for Q4 2023 was $65.83M, a -4.91% decrease from the previous quarter (Q3 2023), and a 5.16% increase year-over-year (Q4 2022).

What is Zai Lab’s revenue growth rate?

Zai Lab's revenue growth rate for the last 3 years (2022-2024) was 85.54%, and for the last 5 years (2020-2024) was 714.96%.

What are Zai Lab’s revenue streams?

Zai Lab's revenue streams in c 24 are Qinlock, Zejula, Nuzyra, and Optune. Qinlock generated $28.83M in revenue, accounting 9.62% of the company's total revenue, up 49.82% year-over-year. Zejula generated $187.08M in revenue, accounting 62.45% of the company's total revenue, up 10.80% year-over-year. Nuzyra generated $43.2M in revenue, accounting 14.42% of the company's total revenue, up 99.48% year-over-year. Optune generated $40.48M in revenue, accounting 13.51% of the company's total revenue, down -13.83% year-over-year.

What is Zai Lab’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Zai Lab was Zejula. This segment made a revenue of $187.08M, representing 62.45% of the company's total revenue.